Identification of neurotoxic cytokines by profiling Alzheimer’s disease tissues and neuron culture viability screeningWood, Levi B.; Winslow, Ashley R.; Proctor, Elizabeth A.; McGuone, Declan; Mordes, Daniel A.; Frosch, Matthew P.; Hyman, Bradley T.; Lauffenburger, Douglas A.; Haigis, Kevin M. · Scientific Reports · 2015

Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s diseaseGrassi, Diego; Howard, Shannon; Zhou, Minghai; Diaz-Perez, Natalia; Urban, Nicolai T.; Guerrero-Given, Debbie; Kamasawa, Naomi; Volpicelli-Daley, Laura A.; LoGrasso, Philip; Lasmézas, Corinne Ida · Proceedings of the National Academy of Sciences · 2018

Development of a method for sample preparation for subsequent identification and measurement of 1,2,3,4-tetrahydroisoquinolines and other potentially neurotoxic compounds by high-performance liquid chromatography with ultraviolet and fluorescence detection in blood plasma of Parkinson’s disease patientsPeter Pagel; Rainer Schubert; Hans Uwe Wolf · 2000

Contributors&NA;, · CONTINUUM: Lifelong Learning in Neurology · 2012

Metabolic MyopathiesTobon, Alejandro · CONTINUUM: Lifelong Learning in Neurology · 2013

Spinal Cord Functional AnatomyCho, Tracey A. · CONTINUUM: Lifelong Learning in Neurology · 2015

Epidemiology and Risk FactorsElkind, Mitchell S. V. · CONTINUUM: Lifelong Learning in Neurology · 2011

The Continued Evolution of EpilepsyLewis, Steven L. · CONTINUUM: Lifelong Learning in Neurology · 2013

CONTRIBUTORS&NA;, · CONTINUUM: Lifelong Learning in Neurology · 2015

Dyslipidemia ManagementBhattacharya, Pratik; Chaturvedi, Seemant · CONTINUUM: Lifelong Learning in Neurology · 2011

Key Points for Issue&NA;, · CONTINUUM: Lifelong Learning in Neurology · 2014